Correlation Between Inozyme Pharma and Supernus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Supernus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Supernus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Supernus Pharmaceuticals, you can compare the effects of market volatilities on Inozyme Pharma and Supernus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Supernus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Supernus Pharmaceuticals.
Diversification Opportunities for Inozyme Pharma and Supernus Pharmaceuticals
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Inozyme and Supernus is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Supernus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Supernus Pharmaceuticals and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Supernus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Supernus Pharmaceuticals has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Supernus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Supernus Pharmaceuticals
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Supernus Pharmaceuticals. In addition to that, Inozyme Pharma is 1.71 times more volatile than Supernus Pharmaceuticals. It trades about -0.01 of its total potential returns per unit of risk. Supernus Pharmaceuticals is currently generating about 0.06 per unit of volatility. If you would invest 2,697 in Supernus Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 885.00 from holding Supernus Pharmaceuticals or generate 32.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Supernus Pharmaceuticals
Performance |
| Timeline |
| Inozyme Pharma |
| Supernus Pharmaceuticals |
Inozyme Pharma and Supernus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Supernus Pharmaceuticals
The main advantage of trading using opposite Inozyme Pharma and Supernus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Supernus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Supernus Pharmaceuticals will offset losses from the drop in Supernus Pharmaceuticals' long position.| Inozyme Pharma vs. Lyra Therapeutics | Inozyme Pharma vs. Hookipa Pharma | Inozyme Pharma vs. Cingulate Warrants | Inozyme Pharma vs. SAB Biotherapeutics |
| Supernus Pharmaceuticals vs. Prestige Brand Holdings | Supernus Pharmaceuticals vs. Evotec SE ADR | Supernus Pharmaceuticals vs. Collegium Pharmaceutical | Supernus Pharmaceuticals vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |